Consolidated Statements of Cash Flows - USD ($)	5 Months Ended	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2018	Jul. 31, 2017
Cash flows provided by (used in) operating activities
Net loss	$ 1,379,379	$ (21,195,316)	$ 6,580,613
Adjustments to reconcile net loss to net cash used by operating activities:
Depreciation and amortization	2,142	2,556	5,140
Issuance of common stock for services	0	732,249	190,427
Stock based compensation from issuance of options	1,779,671	5,760,432	1,277,139
Loss on settlement of liability	13,917	49,983	0
Stock based compensation from issuance of warrants	0	0	229,360
Changes in assets and liabilities:
Accounts receivable	(7,946,676)	7,207,359	(3,437,502)
Prepaid expenses and other current assets	(568,441)	465,705	(102,483)
Accounts payable and accrued expenses	1,145,021	(1,924,032)	2,071,387
License fees payable	0	8,100,000	0
Accrued salaries and wages	(987,870)	370,155	(1,218,065)
Royalty payable	1,408,012	(409,707)	0
Deferred revenue	(65,641)	317,644	(39,854)
Net cash provided by (used in) operating activities	(3,840,486)	(522,972)	5,556,162
Cash flows provided by (used in) financing activities
Proceeds from warrant exercise	5,292,876	34,000	0
Deferred financing costs	(209,042)	(166,419)	0
Proceeds from sale of common stock	0	17,153,126	0
Repayment of note payable	0	0	(165,000)
Net cash provided by (used in) financing activities	5,083,834	17,020,707	(165,000)
Net increase in cash and cash equivalents	1,243,348	16,497,735	5,391,162
Cash and cash equivalents, beginning of period	6,872,555	8,115,903	1,481,393
Cash and cash equivalents, end of period	8,115,903	24,613,638	6,872,555
Supplemental disclosure
Interest paid during the period	0	0	4,828
Taxes paid during the period	619,225	174,000	0
Non-Cash Financing Transactions
Cashless exercise of options	146	50	0
Issuance of common stock to net profit partner	0	1,600,000	0
Issuance of common stock as settlement of liability	200,000	100,000	0
Forgiveness of related party of debt	0	0	761,826
Reconciling adjustment to record shares issued in prior year for the conversion of debt into common stock and rounding in relation to 1-for-100 reverse stock split	0	0	6
Offset of deferred financing costs against APIC	$ 0	$ 209,042	$ 0